|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM220987033 |
| 003 |
DE-627 |
| 005 |
20231224050738.0 |
| 007 |
tu |
| 008 |
231224s2011 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0736.xml
|
| 035 |
|
|
|a (DE-627)NLM220987033
|
| 035 |
|
|
|a (NLM)22973590
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Dabigatran emerges as safe and effective warfarin alternative. The recently approved drug is more expensive, but appears to be more predictable
|
| 264 |
|
1 |
|c 2011
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 20.09.2012
|
| 500 |
|
|
|a Date Revised 21.10.2016
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Anticoagulants
|2 NLM
|
| 650 |
|
7 |
|a Benzimidazoles
|2 NLM
|
| 650 |
|
7 |
|a beta-Alanine
|2 NLM
|
| 650 |
|
7 |
|a 11P2JDE17B
|2 NLM
|
| 650 |
|
7 |
|a Warfarin
|2 NLM
|
| 650 |
|
7 |
|a 5Q7ZVV76EI
|2 NLM
|
| 650 |
|
7 |
|a Dabigatran
|2 NLM
|
| 650 |
|
7 |
|a I0VM4M70GC
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Heart advisor
|d 1999
|g 14(2011), 1 vom: 25. Jan., Seite 4
|w (DE-627)NLM098274252
|x 1523-9004
|7 nnns
|
| 773 |
1 |
8 |
|g volume:14
|g year:2011
|g number:1
|g day:25
|g month:01
|g pages:4
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 14
|j 2011
|e 1
|b 25
|c 01
|h 4
|